Change in COVID-19 Mortality in Patients With Cancer During Pandemic

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6199?guestAccessKey=34bfddf6-8dcb-4cc5-b112-3792eda89ee4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421

 

What The Study Did: Evolving outcomes of COVID-19 in patients with cancer are described in this registry-based study of about 2,600 patients in six European countries.

Authors: Alessio Cortellini, M.D., and David J. Pinato, M.D., Ph.D., of Imperial College London, are the corresponding authors.

 

(doi:10.1001/jamaoncol.2021.6199)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.